Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables
-
Pre-Open Stock Movers 01/22: (EBAY) (UAA) (PANW) Higher; (ARNC) (PETS) (SWK) Lower (more...)
-
Chardan Capital Markets Upgrades Dicerna Pharmaceuticals (DRNA) to Buy
-
uniQure BV (QURE) Named Top 2019 Pick at Chardan
-
Form 8-K Chardan Healthcare Acqui For: Dec 18
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Gnedy Elliot
-
Form SC 13G Chardan Healthcare Acqui Filed by: RTW INVESTMENTS, LP
-
Form SC 13G Chardan Healthcare Acqui Filed by: BOOTHBAY FUND MANAGEMENT, LLC
-
Form 8-K Chardan Healthcare Acqui For: Dec 18
-
Form 4 Chardan Healthcare Acqui For: Dec 18 Filed by: GROSSMAN JONAS
-
Chardan Healthcare Acquisition Corp. Announces Closing of Initial Public Offering
-
Chardan's Equity Research Team Publishes in a Peer-reviewed Journal
-
Neurotrope (NTRP) Appoints Ivan Gergel MD & Jonathan Schechter to Board
-
Neurotrope Announces the Appointment of Two New Board Members
-
Form 424B4 Chardan Healthcare Acqui
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Rossen Matthew
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: RICE YEHUDA MICHAEL
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Kaufman George
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: GROSSMAN JONAS
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Kusseluk Eric
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Amusa Gbolahan
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Giroux Richard
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Chardan Investments, LLC
-
Form EFFECT Chardan Healthcare Acqui
-
Chardan Healthcare Acquisition Corp. (CHAC) Prices 7M Unit IPO at $10/Unit
-
Chardan Healthcare Acquisition Corp. Announces Pricing of $70 Million Initial Public Offering
-
Form CERT Chardan Healthcare Acqui
-
UPDATE: Chardan Capital Markets Starts Synlogic Inc. (SYBX) at Buy
-
Form 8-A12B Chardan Healthcare Acqui
-
Form S-1/A Chardan Healthcare Acqui
-
DealFlow Announces Agenda for The SPAC Conference 2019
-
DealFlow Announces Agenda for The SPAC Conference 2019
-
Form S-1/A Chardan Healthcare Acqui
-
Moderna (MRNA) IPO Opens 4% Lower
-
Moderna (MRNA) Prices 26.276M Share IPO at $23/Sh
-
Moderna Announces Pricing of Initial Public Offering
-
Form S-1/A Chardan Healthcare Acqui
-
Chardan Capital Markets Starts Arcimoto Inc. (FUV) at Buy
-
Form S-1 Chardan Healthcare Acqui
-
I-AM Capital Acquisition Company Announces Closing of Transaction with SMAAASH Entertainment, a fast-growing global virtual reality gaming and sports entertainment company
-
Alberton Acquisition Corporation To Commence Separate Trading of its Ordinary Shares, Rights and Warrants on November 21, 2018; Underwriter To Exercise Over-allotment Option
-
Chardan Capital Markets Starts LogicBio Therapeutics (LOGC) at Buy
-
uniQure BV (QURE) PT Raised to $70 at Chardan Capital Markets
-
Smith Micro Software (SMSI) Announces $7.5 Million Private Placement Offering of Common Stock, Warrants
-
Smith Micro Announces Above Market $7.5 Million Private Placement Offering of Common Stock and Warrants
-
Tabula Rasa Healthcare (TRHC) PT Raised to $91 at Chardan Capital Markets
-
Tivity Health (TVTY) PT Lowered to $41 at Chardan Capital Markets
-
HMS Holdings (HMSY) PT Raised to $37 at Chardan Capital Markets
-
Benefitfocus (BNFT) PT Raised to $43 at Chardan Capital Markets
-
Chardan Capital Markets Starts 4D Pharma Plc (DDDD:LN) at Buy

